Amanta Healthcar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
100.30
0.35 (0.35%)
BSENSE

Mar 05

BSE+NSE Vol: 54.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

54.66 k (0.29%) Volume

Shareholding (Dec 2025)

FII

1.10%

Held by 6 FIIs

DII

7.20%

Held by 5 DIIs

Promoter

63.56%

Are Amanta Healthcare Ltd latest results good or bad?

11-Feb-2026

Amanta Healthcare Ltd's latest results show a significant net profit increase of 282.64% to ₹4.63 crores, but revenue growth is modest at 9.85% and operating margins have contracted, indicating underlying operational challenges. Overall, while profit growth is strong, caution is warranted due to margin compression and capital efficiency concerns.

Amanta Healthcare Ltd's latest results present a mixed picture. On one hand, the company reported a significant net profit of ₹4.63 crores for Q3 FY26, which is a remarkable 282.64% increase compared to the previous quarter. This surge in profit is primarily attributed to reduced interest costs and improved tax efficiency rather than operational performance, as the revenue growth was more modest at 9.85% year-on-year, reaching ₹74.49 crores.<BR><BR>However, the operating margin has contracted by 159 basis points to 20.62%, indicating challenges in maintaining profitability amidst rising costs and competitive pressures. Additionally, while the nine-month net profit has shown a substantial improvement of 73.88% compared to the previous year, this growth has come against a backdrop of only 6.46% revenue expansion.<BR><BR>Overall, while the profit growth is impressive, the underlying issues such as margin compression and capital efficiency concerns suggest that the company is facing significant operational challenges. Therefore, while there are positive aspects, the overall outlook remains cautious due to these structural weaknesses.

View full answer

Should I buy, sell or hold Amanta Healthcare Ltd?

12-Feb-2026

Why is Amanta Healthcare Ltd falling/rising?

05-Mar-2026

As of 04-Mar, Amanta Healthcare Ltd's stock price is rising to 100.60 after two days of decline, outperforming its sector by 1.59%. However, it remains below its moving averages, indicating potential long-term downward trends and declining investor interest.

As of 04-Mar, Amanta Healthcare Ltd's stock price is rising, currently at 100.60, with a change of 0.5 (0.5%) upwards. This increase comes after a trend reversal, as the stock has gained after two consecutive days of decline. Additionally, it has outperformed its sector by 1.59%, indicating a relative strength compared to its peers. However, it is important to note that the stock is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests that while there is a short-term rise, the longer-term trend may still be downward. Furthermore, investor participation appears to be declining, with a delivery volume decrease of 7.78% against the 5-day average, which could indicate waning interest. Overall, the stock's recent rise is a positive sign, but it is accompanied by underlying concerns regarding its longer-term performance and investor engagement.

View full answer

Which are the latest news on Amanta Healthcar?

05-Mar-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.35 times
2

Underperformed the market in the last 1 year

 
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 389 Cr (Micro Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

4.98%

stock-summary
Price to Book

1.85

Revenue and Profits:
Net Sales:
74 Cr
(Quarterly Results - Dec 2025)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.34%
0%
-2.34%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Amanta Healthcare Gains 0.67%: 2 Key Factors Driving This Week’s Move

Announcements stock-summary

Open Market Purchase Of Equity Shares By Promoter

27-Feb-2026 | Source : BSE

We would like to inform you that we have received disclosure in Form C pursuant to Regulation 7(2) of the SEBI (PIT) REGULATION 2015 from the Promoter.

Announcement under Regulation 30 (LODR)-Credit Rating

16-Feb-2026 | Source : BSE

Announcement under Regulation 30 (LODR) - Credit Rating

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

16-Feb-2026 | Source : BSE

Announcement under Regulation 30 (LODR) - Earnings Call Transcript

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-2.00%
EBIT Growth (5y)
9.30%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
1.99
Sales to Capital Employed (avg)
0.80
Tax Ratio
28.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.34%
ROCE (avg)
13.97%
ROE (avg)
8.18%

Valuation key factors

Factor
Value
P/E Ratio
37
Industry P/E
32
Price to Book Value
1.85
EV to EBIT
11.46
EV to EBITDA
7.93
EV to Capital Employed
1.61
EV to Sales
1.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.03%
ROE (Latest)
4.98%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Mildly Bearish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.99%)

FIIs

Held by 6 FIIs (1.1%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.1%)

Highest Public shareholder

Bandhan Small Cap Fund (3.99%)

Individual Investors Holdings

16.91%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.49",
          "val2": "70.89",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.36",
          "val2": "14.65",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.06",
          "val2": "5.15",
          "chgp": "-1.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.63",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.63",
          "val2": "1.21",
          "chgp": "282.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.62%",
          "val2": "20.67%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.19",
          "val2": "134.83",
          "chgp": "1.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.54",
          "val2": "27.28",
          "chgp": "8.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.44",
          "val2": "15.77",
          "chgp": "-27.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.71",
          "val2": "1.90",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "20.23%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.68",
          "val2": "202.64",
          "chgp": "3.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "44.90",
          "val2": "42.34",
          "chgp": "6.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.50",
          "val2": "21.67",
          "chgp": "-23.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.34",
          "val2": "6.18",
          "chgp": "51.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.31%",
          "val2": "20.89%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.71",
          "val2": "280.34",
          "chgp": "-2.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.67",
          "val2": "57.49",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.95",
          "val2": "33.64",
          "chgp": "-16.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.50",
          "val2": "3.63",
          "chgp": "189.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.72%",
          "val2": "20.51%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
74.49
70.89
5.08%
Operating Profit (PBDIT) excl Other Income
15.36
14.65
4.85%
Interest
5.06
5.15
-1.75%
Exceptional Items
0.00
-2.63
100.00%
Standalone Net Profit
4.63
1.21
282.64%
Operating Profit Margin (Excl OI)
20.62%
20.67%
-0.05%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
136.19
134.83
1.01%
Operating Profit (PBDIT) excl Other Income
29.54
27.28
8.28%
Interest
11.44
15.77
-27.46%
Exceptional Items
-2.63
0.00
Standalone Net Profit
4.71
1.90
147.89%
Operating Profit Margin (Excl OI)
21.69%
20.23%
1.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
210.68
202.64
3.97%
Operating Profit (PBDIT) excl Other Income
44.90
42.34
6.05%
Interest
16.50
21.67
-23.86%
Exceptional Items
-2.63
0.00
Standalone Net Profit
9.34
6.18
51.13%
Operating Profit Margin (Excl OI)
21.31%
20.89%
0.42%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
274.71
280.34
-2.01%
Operating Profit (PBDIT) excl Other Income
59.67
57.49
3.79%
Interest
27.95
33.64
-16.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.50
3.63
189.26%
Operating Profit Margin (Excl OI)
21.72%
20.51%
1.21%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Amanta Healthcare Ltd stock-summary
stock-summary
Amanta Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm "Marck Parenterals (India)" on January 06, 1995. The Company name was changed to "Marck Biosciences Limited" vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005 and was again changed to "Amanta Healthcare Limited" dated June 24, 2014.
Company Coordinates stock-summary
Icon
No Company Details Available